Obserwuj
Ewa Wrona
Ewa Wrona
Nieznane powiązanie
Zweryfikowany adres z stud.umed.lodz.pl
Tytuł
Cytowane przez
Cytowane przez
Rok
CAR-NK cells in the treatment of solid tumors
E Wrona, M Borowiec, P Potemski
International journal of molecular sciences 22 (11), 5899, 2021
882021
Leukemia inhibitory factor: a potential biomarker and therapeutic target in pancreatic cancer
E Wrona, P Potemski, F Sclafani, M Borowiec
Archivum immunologiae et therapiae experimentalis 69, 1-8, 2021
192021
Remission of thymoma on steroid therapy in a patient with atypical thymoma-associated multiorgan autoimmunity: a case report and literature review
E Wrona, S Dębska-Szmich, M Pastuszka, M Braun, R Czyżykowski, ...
Frontiers in Immunology 12, 584703, 2021
92021
The Stricter the Better? The Relationship between Targeted HbA 1c Values and Metabolic Control of Pediatric Type 1 Diabetes Mellitus
M Braun, B Tomasik, E Wrona, W Fendler, P Jarosz-Chobot, ...
Journal of Diabetes Research 2016, 2016
92016
FORUM MŁODYCH Isolated coronary artery bypass grafting in extracorporeal circulation in patients over 65 years old–does age still matter?
D Miśkowiec, A Walczak, S Ostrowski, E Wrona, K Bartczak, R Jaszewski
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and …, 2014
92014
MLPA as a complementary tool for diagnosis of chromosome 21 aberrations in childhood BCP-ALL
E Wrona, M Braun, A Pastorczak, J Taha, M Lejman, J Kowalczyk, ...
Journal of Applied Genetics 60, 347-355, 2019
52019
The stricter the better
M Braun, B Tomasik, E Wrona, W Fendler, P Jarosz-Chobot, ...
The relationship between targeted HbA1c values and metabolic control of …, 0
5
Gene expression of ASNS, LGMN and CTSB is elevated in a subgroup of childhood BCP‑ALL with PAX5 deletion
E Wrona, J Jakubowska, B Pawlik, A Pastorczak, J Madzio, M Lejman, ...
Oncology letters 18 (6), 6926-6932, 2019
42019
A novel immunotherapy—the history of CAR T-cell therapy
E Wrona, P Potemski
Oncology in Clinical Practice 15 (4), 202-207, 2019
42019
Early effects of nivolumab and ipilimumab combined immunotherapy in the treatment of metastatic melanoma in Poland: a multicenter experience
R Pacholczak-Madej, A Grela-Wojewoda, M Puskulluoglu, J Lompart, ...
Biomedicines 10 (10), 2528, 2022
22022
Jednoczesne usunięcie śluzaka lewego przedsionka i rewaskularyzacja mięśnia sercowego–opis przypadku
S Ostrowski, E Wrona, A Kośmider, R Zwoliński, A Marcinkiewicz, ...
Kardiochirurgia i Torakochirurgia Polska 8 (2), 201-204, 2011
22011
An unusual non‑metastatic, mismatch repair‑deficient primary gastric squamous cell carcinoma presenting as a large, exophytic, bleeding tumor: A case report
J Jakubik, A Majos, D Jesionek-Kupnicka, E Wrona, A Kaufman-Szymczyk, ...
Oncology Letters 25 (2), 1-7, 2023
12023
Relationship of adverse events after combined immunotherapy and treatment outcomes in patients with advanced melanoma: A multicenter experience in Poland.
R Pacholczak-Madej, A Grela-Wojewoda, M Puskulluoglu, J Lompart, ...
Journal of Clinical Oncology 41 (16_suppl), e21511-e21511, 2023
2023
Nowoczesna immunoterapia nowotworów—historia terapii komórkami CAR-T
E Wrona, P Potemski
Onkologia w Praktyce Klinicznej-Edukacja 5 (4), 249-256, 2019
2019
Terapia czerniaka złośliwego z zastosowaniem pembrolizumabu—opis przypadku
E Wrona
Onkologia w Praktyce Klinicznej-Edukacja 3 (D), 42-45, 2017
2017
Simultaneous resection of left atrial myxoma and cardiac revascularization
S Ostrowski, E Wrona, A Kośmider, R Zwoliński, A Marcinkiewicz, ...
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and …, 2011
2011
Simultaneous resection of left atrial myxoma and cardiac revascularization
E Wrona, R Zwoliński, A Marcinkiewicz, D Miśkowiec
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–17